Nicola Baldini, MD

Photo of Nicola Baldini MD
Nicola Baldini, MD

Personal information - Education and work experience

Medical Director, under agreement with the University of Bologna

Head of the Simple Structure “Orthopedic pathophysiology and regenerative medicine” (deliberation n.53 of February 12th, 2015).

Degree in Medicine and Surgery at the University of Bologna (1981).

Specialization in Oncology in 1990 (University of Bologna).
Specialization in Orthopaedics and Traumatology in 1987 (University of Bologna).

  • From 2015: Member of the Council of the School of Medicine and Surgery, University of Bologna.
  • From 2015: Member of the Joint Committee of the School of Medicine and Surgery, University of Bologna.
  • From 2011: Head of Simple Structure Department, Rizzoli Orthopaedic Institute.
  • From 2008:Associate Professor of Diseases of the Locomotor System, University of Bologna.
  • From 2000: Technical-scientific Head at the Laboratory of Orthopedic pathophysiology and regenerative medicine, Rizzoli Orthopaedic Institute.
  • From 1999: Medical Director of Orthopedics and Traumatology, Rizzoli Orthopaedic Institute.
  • 1990 – 1999: Medical Director (research area), Laboratory of Oncological Research, Rizzoli Orthopaedic Institute.
  • 1989 – 1990: Fellow in Orthopaedic Surgery, Harvard Medical School & Massachusetts General Hospital, Boston, USA.
  • 1986: Visiting Fellow, Department of Orthopaedic Surgery, Mount Sinai Hospital, Toronto, Canada.
  • 1987 – 1989: Contract MD, Tumors Center, Rizzoli Orthopaedic Institute.
  • 1982 – 1987: Scholarship holder, University of Bologna, Rizzoli Orthopaedic Institute.
  • 1981: Visiting Fellow, Department of Surgery, Alder Hey Children’s Hospital, Liverpool, UK.

Fluent English.

  • 2016: Director of the Permanent Training Course in Experimental and Reconstructive Microsurgery, University of Bologna.
  • From 2013: Coordinator of the Degree Course in Podology, University of Bologna.
  • From 2013: Visiting Professor, Kyoto Prefectural University of Medicine.
  • From 2012: Qualification as Full Professor of Diseases of the Locomotor System.
  • From 2008: Confirmed Associate Professor of Diseases of the Locomotor System, Department of Biomedical and Neuromotor Sciences, University of Bologna.
  • From 2008: Member of the Teaching Board of the Doctorate School of Biomedical and Neuromotor Sciences, University of Bologna.
  • From 2013: Member of the Steering Committee, International Combined Orthopaedic Research Society (ICORS).
  • From 2012: Member of the Board of the International Society for Cancer Metabolism (ISCAM).
  • 2009 – 2012: President of the Italian Society of Researches in Orthopedics and Traumatology (IORS).
  • 2009 - 2012: Member of the Steering Committee, Forum of Italian Researchers on Mesenchymal Stromal Stem Cells (FIRST).
  • 2009 – 2012: Scientific Representative, Center of Biomedical Visualization, Department of Human Anatomy Sciences and Physiopathology of the Locomotor System, University of Bologna.
  • 2008 – 2012: President, Orthopaedic Research Society (EORS).
  • From 2006: Member of the EORS Board.
  • 2005 – 2015: Member of the IORS Directive Council.
  • From 2000: Member of the Scientific Council, “G. Prodi” Interdepartmental Center for Tumor Research, University of Bologna.
  • 1999-2000: President, Connective Tissue Oncology Society (CTOS).

Honorary member of the Giona Academy.
Marco Polo Prize for Italian Science (2014).


Participation to research projects in the last 5 years:

  • From 2015: Head of the AIRC project "Targeting tumor-stroma interaction in sarcoma microenvironment to inhibit the development of metastases".
  • From 2015: Head of the project “Clinical and in vitro study on the efficacy of alkaline citrates in the treatment of osteopenias” by the Foundation Del Monte of Bologna and Ravenna.
  • From 2011: Unit Head in the Region-University project "Regenerative medicine of cartilage and bone".
  • 2011-2014: Head of the AIRC project “Multimodal treatment of musculoskeletal sarcomas by targeting proton dynamics and acidic microenvironment”.
  • 2011-2013: Head of Operative Unit in the MIUR-FIRB project “Tumoral stem cells: signal transduction pathways as targets for potential therapies”.
  • From 2010: Unit Head in the Region-University project "Use of biomarkers and gene expression profiles to identify cancer patients with different prognosis and sensitivity to molecular target agents".
  • 2009-2015: Head of Operative Unit in the EC-FP7 project “Regenerating bone defects using new biomedical engineering approaches (REBORNE)”.


Review editor for "Musculoskeletal Surgery".

Section Editor (Basic Science) of the review "European Orthopaedics and Traumatology".
Member of the Editorial Board for the reviews: "Journal of Circularing Biomarkers", "Journal of Orthopaedic Translation", "Frontiers in Cell and Developmental Biology".

Reviewer for: Acta Orthopaedica, American Journal of Pathology, Biomaterials, BMC Research Notes, British Journal of Cancer, Cancer, Cell Cycle, European Cell Materials, European Journal of Cancer, Histochemical Journal, International Journal of Cancer, Journal of Clinical Oncology, Journal of Urology, Nature Medicine, Oncogene, Oncology, Oncotarget, PLOS ONE, Scientific Reports, Stem Cell and Development, Stem Cell International, The Lancet.


Research project reviewer for the following bodies: Agence Nationale de la Recherche; Agenzia Nazionale di Valutazione del Sistema Universitario e della Ricerca; Agenzia Spaziale Italiana; Human Frontier Science Program; Canadian Institutes of Health Research; Cancer Society of New Zealand; Centro Investigación Biomédica en Red Bioingeniería, Biomateriales y Nanomedicina; Compagnia di San Paolo; Istituto Superiore di Sanità. National Canine Defense League. Société Française de Lutte contre les Cancers et Leucémies de l'Enfant et de l'Adolescent; Università di Catania.


Author of over 240 articles on PubMed and Scopus-indexed reviews. Total quotations: >6500 (Scopus); >9100 (Google Scholar). Total IF: 905. H-Index: 45 (Scopus); 52 (Google Scholar).
Author of 3 books, 31 book chapters, 1 patent, 54 seminars and conferences upon invitation, over 440 congress presentations.

Oncological orthopedics; physiopathology and metabolism of the bone; regenerative medicine in the orthopedic field; biomaterials for orthopedic implants; biologic and synthetic nanostructures for theranostics.

Content updated 30/05/2017 - 08:56
Utilizza SharethisShareThis  Scrivi una email  Vai a facebook  Vai a twitter